Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.
Saved in:
| Title: | Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer. |
|---|---|
| Authors: | Jazieh K; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America., Carlson EE; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America., Siddiqui Z; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America., Connelly KE; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Zhong J; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Hoskins JW; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Rabe KG; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America., Oberg AL; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America., Sicotte H; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America., Carr RM; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America., Amundadottir LT; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Antwi SO; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Jacksonville, Florida, United States of America. |
| Corporate Authors: | MAYO-RGC Project Generation, Regeneron Genetics Center |
| Source: | PloS one [PLoS One] 2026 Feb 19; Vol. 21 (2), pp. e0343022. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41712602 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jazieh+K%22">Jazieh K</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Carlson+EE%22">Carlson EE</searchLink>; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Siddiqui+Z%22">Siddiqui Z</searchLink>; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Connelly+KE%22">Connelly KE</searchLink>; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhong+J%22">Zhong J</searchLink>; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hoskins+JW%22">Hoskins JW</searchLink>; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Rabe+KG%22">Rabe KG</searchLink>; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Oberg+AL%22">Oberg AL</searchLink>; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Sicotte+H%22">Sicotte H</searchLink>; Department of Quantitative Health Sciences, Computational Biology, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Carr+RM%22">Carr RM</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Amundadottir+LT%22">Amundadottir LT</searchLink>; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Antwi+SO%22">Antwi SO</searchLink>; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Jacksonville, Florida, United States of America. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22MAYO-RGC+Project+Generation%2C+Regeneron+Genetics+Center%22">MAYO-RGC Project Generation, Regeneron Genetics Center</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2026 Feb 19; Vol. 21 (2), pp. e0343022. <i>Date of Electronic Publication: </i>2026 Feb 19 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41712602 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0343022 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0343022 Titles: – TitleFull: Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jazieh K – PersonEntity: Name: NameFull: Carlson EE – PersonEntity: Name: NameFull: Siddiqui Z – PersonEntity: Name: NameFull: Connelly KE – PersonEntity: Name: NameFull: Zhong J – PersonEntity: Name: NameFull: Hoskins JW – PersonEntity: Name: NameFull: Rabe KG – PersonEntity: Name: NameFull: Oberg AL – PersonEntity: Name: NameFull: Sicotte H – PersonEntity: Name: NameFull: Carr RM – PersonEntity: Name: NameFull: Amundadottir LT – PersonEntity: Name: NameFull: Antwi SO IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 02 Text: 2026 Feb 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 21 – Type: issue Value: 2 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |